Wednesday, July 15, 2026

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

Marijuana Madness: Man Kills Pet Dog in Drug-Induced State

A man in his twenties who confessed...

SleepQ vs. Traditional Medications: Which is the Future of Insomnia Treatment?

Welt aims to complete clinical trials for its SleepQ insomnia device by year-end, targeting listing on Germany's DiGA reimbursement system.

Tag: external information

No posts to display

Top News

- Our Sponsors Ad -

Follow us